It was significantly higher than MCPIP1 mRNA expression in the biopsies from both healthy controls (CTR) (0.0080 ± 0.0034, p < 0.001) and non-lesional skin of HS patients (HS-2: non-lesional skin) (0.0049 ± 0.0034, p < 0.001) (Figure 1A). This evidence concerns the gene ZC3H12A and histiocytic sarcoma.